“Clinical Efficacy or Tildrakizumab in Patients with Chronic Plaque Psoriasis Over 2 Years of Treatment: Results from Long-Term Extensions to 2 Phase 3 Clinical Studies” (2018) SKIN The Journal of Cutaneous Medicine, 2(S1), p. S4. doi:10.25251/skin.2.supp.4.